Option chain shows key data for Pheton Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Pheton Holdings.

Pheton Holdings (NASDAQ:PTHL) Stock, Option Chain

Pheton Holdings

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings Ltd

News

NYSE To Begin Delisting Proceedings Against Lion Electric Company

Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) has outperformed the market over the past 5 years by 21.59% on an annualized basis producing an average annual return of 34.38%. Currently, Dell Technologies has a market capitalization of $78.92 billion. 
Buying $100 In DELL: If an investor had bought $100 of DELL stock 5 years ago, it would be worth $441.39 today based on a price of $112.67 for DELL at the time of writing.
<h3>Dell Technologies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734556520_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

DELL

Here's How Much $100 Invested In Dell Technologies 5 Years Ago Would Be Worth Today

Offerings

The Marygold Companies, Inc. Common Stock

MGLD

Marygold Companies Files For Mixed Shelf Offering Of Up To $100M

Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) reported its Q3 earnings results on Wednesday, December 18, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Steelcase beat estimated earnings by 36.0%, reporting an EPS of $0.3 versus an estimate of $0.22.
Revenue was up $17.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
In the previous quarter, the company beat on EPS by $0.02, resulting in a 6.0% drop change in the share price the following day.
Here's a look at Steelcase's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.37</td>
<td>0.10</td>
<td>0.21</td>
<td>0.23</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.39</td>
<td>0.16</td>
<td>0.23</td>
<td>0.30</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>864.10M</td>
<td>729.12M</td>
<td>780.25M</td>
<td>798.65M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>855.80M</td>
<td>727.30M</td>
<td>775.20M</td>
<td>777.90M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Steelcase <a href="https://www.benzinga.com/quote/SCS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Earnings Summary: Steelcase Q3

Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) has outperformed the market over the past 20 years by 14.16% on an annualized basis producing an average annual return of 22.39%. Currently, Old Dominion Freight Line has a market capitalization of $40.94 billion. 
Buying $100 In ODFL: If an investor had bought $100 of ODFL stock 20 years ago, it would be worth $5,685.71 today based on a price of $191.77 for ODFL at the time of writing.
<h3>Old Dominion Freight Line's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734556514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ODFL

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

The earnings results for MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) for Q2 were made public on Wednesday, December 18, 2024 at 04:05 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
MillerKnoll beat estimated earnings by 4.0%, reporting an EPS of $0.55 versus an estimate of $0.53.
Revenue was up $20.90 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
Last quarter the company missed on EPS by $0.04 which was followed by a 14.000000000000002% drop in the share price the next day.
Here's a look at MillerKnoll's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.40</td>
<td>0.53</td>
<td>0.44</td>
<td>0.55</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.36</td>
<td>0.67</td>
<td>0.45</td>
<td>0.59</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>889.30M</td>
<td>898.67M</td>
<td>909.50M</td>
<td>973.82M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>861.50M</td>
<td>888.90M</td>
<td>872.30M</td>
<td>949.50M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
MillerKnoll management provided guidance for Q3 2025, expecting earnings between $0.41 and $0.47 per share.
To track all earnings releases for MillerKnoll <a href="https://www.benzinga.com/quote/MLKN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MLKN

Earnings Summary: MillerKnoll Q2

Management

HOOD

On December 16, 2024, Robinhood Markets Appoints Christopher Payne To Board, Effective Immediately - Filing

Financial Highlights from our Fiscal Year 2024:
<ul>
<li>Net sales totaled $19.5 million in fiscal 2024 or a decrease of 19.1% compared to $24.1 million in fiscal 2023.</li>
<li>Our gross profit for the year was flat at 62% in fiscal 2024 compared to 62% in fiscal 2023.</li>
<li>Our loss from operations was $3.3 million in fiscal 2024 as compared to a loss of $22.4 million in fiscal 2023.</li>
<li>Our non-GAAP adjusted EBITDA loss from operations in fiscal 2024 was approximately $1.5 compared to our non-GAAP adjusted EBITDA from operations in fiscal 2023 of approximately $5.5. million, despite the decline in revenue. Our non-GAAP adjusted EBITDA loss for the second half of 2024 was reduced to only $0.2 million from $1.2 million in the prior year comparative period.</li>
<li>Net loss attributable to common shareholders for fiscal 2024 was approximately $7.7 million or $1.79 per share as compared to a net loss for fiscal 2023 of approximately $26.9 million, or $13.30 per share. The improvement in fiscal 2024 was principally attributable to ongoing management's efforts on improving profitability, as well as the $13.2 million intangible impairment during 2023.</li>
<li>At September 30, 2024, we had working capital of approximately $1.1 million and cash on hand of approximately $2.4 million (which includes $4.7 million of accrued Series A dividend payments) as compared to working capital of approximately $3.4 million and cash on hand of approximately $1.8 million (which includes $0.67 million of accrued Series A dividend payments) at September 30, 2023.</li>
<li>We reported direct to consumer (DTC) net sales of $15.7 million or 80.4% of total net sales in fiscal 2024, a decrease of $3.9 million, or 19.9% from fiscal 2023.</li>
<li>As of the filing date of our annual report, the majority of our Notes have been converted and the balance of the Notes totaled approximately $0.36 million. When factoring in our cash balance of $2.4 million at the end of September 30, 2024 and ongoing cash consumption rate, management believe the Company has a strong liquidity position going into calendar 2025.</li>
</ul>
Pursuant to the disclosure requirements of the NYSE American Company Guide Section 610(b), cbdMD is reporting that its audited consolidated financial statements for the fiscal year ended September 30, 2024, included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission on December 18, 2024, contains an audit opinion from its independent registered public accounting firm that includes an explanatory paragraph related to cbdMD's ability to continue as a going concern. This announcement does not represent any change or amendment to cbdMD's financial statements or to its Annual Report on Form 10-K for the fiscal year ended September 30, 2024.
We will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss our September 30, 2024, fourth quarter and full fiscal year financial results and business progress.

YCBD

cbdMD FY24 EPS $(1.79) Up From $(13.32) YoY; Revenue $19.48M Down From $24.16M YoY

WIIM

Worthington Steel shares are trading lower. The company reported Q2 financial results.

The securities sale is part of the Company's strategy to proactively maximize the balance sheet with the goal of driving future earnings.&nbsp;
The securities sold represented approximately 20% of the Company's AFS portfolio and resulted in an after-tax loss of approximately $5 million that will be recorded in the fourth quarter of 2024. Proceeds from the sale will be redeployed over time into higher yielding securities.

NBHC

National Bank Holdings Reports Sale Of $130M Of Available-For-Sale Investment Securities On The Open Market

Steelcase shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) reported quarterly earnings of $0.19 per share. This is a 72.73 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $739.00 million which beat the analyst consensus estimate of $719.45 million by 2.72 percent. This is a 8.54 percent decrease over sales of $808.00 million the same period last year.

Earnings Beats

Worthington Steel Q2 Adj $0.19 Up From $0.11 YoY, Sales $739.00M Beat $719.45M Estimate

Guidance

Steelcase Sees Q4 Adj. EPS $0.20-$0.24 Vs $0.22 Est.; Revenue $770M-$795M Vs $834.560M Est.

Contracts

Trane Technologies Announced It Has Signed A Definitive Agreement To Aquire BrainBox AI; Terms Not Disclosed

Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.22 by 36.36 percent. The company reported quarterly sales of $794.900 million which missed the analyst consensus estimate of $800.580 million by 0.71 percent. This is a 2.19 percent increase over sales of $777.900 million the same period last year.

Earnings Misses

Steelcase Q3 2025 Adj. EPS $0.30 Beats $0.22 Estimate, Sales $794.900M Miss $800.580M Estimate

Third Quarter and Fiscal 2025 Outlook The table below presents our expectations for third quarter and selected full year fiscal 2025 financial operating results:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Q3 FY2025</td>
<td colspan="1" rowspan="1">Full Year FY25</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net sales</td>
<td colspan="1" rowspan="1">$903 million to $943 million</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gross margin %</td>
<td colspan="1" rowspan="1">38.1% to 39.1%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted operating expenses&#x2A;</td>
<td colspan="1" rowspan="1">$293 million to $303 million</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest and other expense, net</td>
<td colspan="1" rowspan="1">$16.7 million to $17.7 million</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted effective tax rate&#x2A;</td>
<td colspan="1" rowspan="1">21.5% to 23.5%</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted earnings per share - diluted&#x2A;</td>
<td colspan="1" rowspan="1">$0.41 to $0.47</td>
<td colspan="1" rowspan="1">$2.11 to $2.17</td>
</tr>
<tr>
<td colspan="3" rowspan="1">&#x2A;Items indicated represent Non-GAAP measures. The Q3 FY2025 outlook excludes an expected $6 million in operating expense charges related to amortization of Knoll purchased intangibles and the related tax and earnings per share impact.</td>
</tr>
</tbody>
</table>
</figure>
We are encouraged with both internal and external indicators that collectively support an expectation of improving demand trends in most of our markets.&nbsp; While we expect our fiscal third quarter to be impacted by typical seasonal softness in our Americas and International Contracts businesses as the calendar year comes to a close and by the timing of the Chinese New Year holiday, our full year guide reflects the improving demand trends. We narrowed our full year adjusted earnings per share range and modestly lowered the midpoint given the slower than expected macroeconomic improvements and lower than expected orders in the first half of the year. Our updated guidance continues to reflect full year sales and EPS growth over fiscal 2024.&nbsp;
Due to the timing dynamic of this year's holiday/cyber promotional period, we estimate approximately $12 million in Global Retail net sales shifted from our fiscal second quarter into our fiscal third quarter, as compared to the prior year.&nbsp; This is reflected in our third quarter guidance.

MillerKnoll Sees Q3 EPS $0.41-$0.47 Vs $0.56 Est.; Revenue $903M-$943M Vs $927.15M Est.

Biotech

General

IRIX

Iridex Publishes Peer-Reviewed Study In Ophthalmology Therapy; Highlights Safety And Efficacy Of MicroPulse Transscleral Laser Therapy In Managing Both Primary And Secondary Glaucoma Over Five Years.

<h3>Gainers</h3>
<ul>
<li>Worthington Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) stock moved upwards by 16.1% to $44.37 during Wednesday's pre-market session. The company's market cap stands at $2.2 billion. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) shares rose 12.65% to $1.78. The company's market cap stands at $22.4 million. </li>
<li>Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) shares moved upwards by 12.46% to $3.7. The company's market cap stands at $39.9 million. </li>
<li>Cango (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) shares increased by 12.15% to $7.75. The market value of their outstanding shares is at $808.8 million. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) stock increased by 9.57% to $0.79. The market value of their outstanding shares is at $2.0 million. </li>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) stock moved upwards by 9.57% to $1.6. The company's market cap stands at $14.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock decreased by 27.0% to $28.01 during Wednesday's pre-market session. The market value of their outstanding shares is at $563.1 million. </li>
<li>XWELL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XWEL#NASDAQ">XWEL</a>) shares decreased by 9.45% to $1.62. The company's market cap stands at $8.5 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) shares fell 8.53% to $0.08. The company's market cap stands at $1.4 million. </li>
<li>Hesai Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) shares decreased by 7.62% to $12.86. The market value of their outstanding shares is at $1.6 billion. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) stock declined by 7.6% to $2.31. The company's market cap stands at $2.6 million. </li>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock fell 5.61% to $1.18. The company's market cap stands at $12.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CANG

EZGO

FTEL

HSAI

ISPO

JZXN

LXEH

RIME

VNCE

XWEL

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

SVRA

Savara Initiates Rolling Submission Of Biologics License Application To FDA For MOLBREEVI In Potential Treatment Of Autoimmune Pulmonary Alveolar Proteinosis

Parsons Announced It Has Been Awarded $20M U.S. Army Corps Of Engineers Contract For Puerto Rico Microgrid

U.S. IPO Weekly Recap: 2 APAC Microcaps Go Public In Short Labor Day Week As The Pipeline Grows

Pheton Holdings and Powell Max opened for trading on Thursday at $3.76 and $4.30, respectively. While the number of initial public offerings has rebounded from 2023, IPOs remain well below pre-pandemic levels.

Pheton, Powell Max Make Public Debut

Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials.

Comments

Pheton Holdings

Pheton Holdings (PTHL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga